NCT02181127View on ClinicalTrials.gov

Closed-Loop Glucagon Administration For Hypoglycemia Treatment

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

April 30, 2017

Conditions
Type 1 Diabetes
Interventions
DEVICE

Glucagon-only Bionic Pancreas

A computer algorithm will automatically deliver glucagon based on the signal from a minimally invasive continuous glucose monitor.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Boston University

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02181127 - Closed-Loop Glucagon Administration For Hypoglycemia Treatment | Biotech Hunter | Biotech Hunter